FINESALER Recall (March 2026): Alain MILLIAT

On March 26, 2026, FINESALER LLC began a Class II recall. Reason: Product may contain foreign objects, specifically glass.

In plain words

What

Alain MILLIAT; MARMELADE ORANGE; 300 g 10.6 oz; packaged in glass jars

Why

Product may contain foreign objects, specifically glass.

Where

Massachusetts.

Distribution as reported to FDA: MA

How serious

Class II: the FDA uses this class for a situation where eating the product may cause temporary or medically reversible health problems, or where the chance of serious health problems is remote.

Status: Terminated. FDA has closed the recall. Closed May 27, 2026.

What to do

Compare the product name, size, UPC and lot or date codes below with what you have. The FDA Enforcement Report is the official record of this recall; for instructions on returns or refunds, follow the notice or contact FINESALER LLC.

Official notice ↗

The recalled product1

FDA recall H-0773-2026 · Class II · Terminated

Alain MILLIAT; MARMELADE ORANGE; 300 g 10.6 oz; packaged in glass jars

Codes:
C250422AT DDM: 04/2028
Quantity:
1 case (6 jars)

Recall record

Agency
U.S. Food and Drug Administration (FDA)
Recalling firm
FINESALER LLC, Mamaroneck, NY
Recall started
March 26, 2026
FDA Enforcement Report
May 20, 2026
Initiated
Voluntary: Firm initiated
Recall number
H-0773-2026
FDA event ID
98727

Latest food recalls

JXK Enterprises, Inc is voluntarily recalling Boner Bears Chocolate, Lot #BB21125, after being notified that FDA laboratory analysis confirmed the presence of sildenafil, an active ingredient in the FDA-approved prescription drug Viagra, which is not declared on the product label.

Nationwide · Ongoing

All food recalls

Recall details come from the U.S. Food and Drug Administration's Enforcement Reports (through openFDA) and from USDA's Food Safety and Inspection Service recalls and public health alerts, checked daily. MealSlash shows what the agency published and links every recall to its official notice; the notice is the authority. openFDA's note: do not rely on openFDA to make decisions regarding medical care.